| Size & multiples | |||
| Market Cap | $2.02B | Enterprise Value | $1.92B |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 3.55× | P/FCF | 38.07× |
| EV/EBITDA | 56.75× | EV/EBIT | 148.58× |
| EV/Sales | 3.36× | EV/FCF | 36.06× |
| FCF Yield | 2.63% | Buyback Yield | — |
| Owner Earnings (TTM) | $19.6M | Owner Earnings Yield | 0.97% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.16 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 9.79% |
| After-tax Cost of Debt | — | Synthetic credit rating | B |
| Cost of Debt · embedded (pre-tax) | 9.23% | Cost of Debt · marginal (synthetic) | 7.21% |
| WACC | — | ROIC | −1.89% |
| EVA Spread (ROIC−WACC) | — | EVA | — |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$0.24 · revenue TTM $569.6M · FCF TTM $53.1M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | 2.4% | -7.8% | -34.7%–1.4% | 78 ↑strong |
| Net Margin | -2.1% | -21.2% | -325.3%–7.2% | 63 ↑strong |
| Operating Margin | -1.8% | -34.5% | -552.0%–8.0% | 66 ↑strong |
| ROE | -2.4% | -36.8% | -92.5%–4.5% | 71 ↑strong |
